STOCKSCREENR

0HI3.L

LSE

Arrowhead Pharmaceuticals, Inc.

$73.15+3.94(+5.70%)Mkt Cap: $10.01B

Key Stats

Market Cap

$10.01B

P/E Ratio

-68.05

EPS

$-1.07

Dividend Yield

0.00%

52-Week Range

$20.75 — $73.15

Volume

331

Avg Volume

1.78K

Beta

1.27

Price Alerts for 0HI3.L

Get alerted when 0HI3.L hits your target price.

$

Free — enter your email to get started

Valuation

P/E (TTM)

-68.05

Forward P/E

—

PEG Ratio

0.00

P/S (TTM)

9.05

P/B (TTM)

17.38

P/FCF

—

EV/EBITDA

—

EV/Sales

—

Financial Health

ROE (TTM)

0.36%

ROA (TTM)

0.13%

ROIC

—

Gross Margin

0.98%

Operating Margin

0.28%

Net Margin

—

Debt/Equity

0.55

Current Ratio

3.38

Growth

EPS Growth (YoY)

—

Revenue Growth (YoY)

—

EPS Growth (3Y)

-0.25%

EPS Growth (5Y)

-0.32%

Sales Growth (3Y)

+77.20%

Sales Growth (5Y)

+46.58%

EPS Est (This Year)

$-3.21

EPS Est (Next Year)

$-4.08

Dividends

Dividend Yield

—

Annual Dividend

—

Payout Ratio

—

Frequency

—

Ex-Dividend Date

—

Cash/Share

$6.54

Ownership

Institutional %

—

Inst. Net Change

—

Insider Net Shares (90d)

-10000

Outstanding Shares

136.80M

Float

122.03M

Free Float %

89.20%

Technicals

RSI (14)

41.33

SMA 20

$66.83

SMA 50

$66.24

SMA 200

$38.37

ATR (14)

3.55

Volatility (Week)

0.04%

Volatility (Month)

0.04%

Pattern

—

Performance

1 Day

-0.40%

1 Week

-7.73%

1 Month

-5.34%

3 Months

+64.86%

6 Months

+282.76%

1 Year

—

YTD

-8.23%

All-Time High

$76.20

About

Sector

Healthcare

Industry

Biotechnology

Country

US

Exchange

LSE

IPO Date

2018-01-29

Employees

609

CEO

Christopher R. Anzalone

Index Membership

—

Website

https://arrowheadpharma.com

Arrowhead Pharmaceuticals, Inc. (0HI3.L) is a healthcare company in the biotechnology industry listed on the LSE. With a market capitalization of $10.01B, a P/E ratio of -68.05, 0HI3.L is tracked by stockscreenr alongside 25,000+ other tickers. Use the free stock screener to compare 0HI3.L against other stocks using dozens of fundamental and technical filters.

Similar Stocks

NUVL

Nuvalent, Inc.

$100.28

+1.19%

$7.34B

ARGX

argenx SE

$781.72

+0.73%

$48.38B

ANAB

AnaptysBio, Inc.

$65.73

+5.44%

$2.83B

0QW0.L

argenx SE

$661.80

+1.77%

$25.13B

RNAM

Avidity Biosciences Inc

$72.86

+0.05%

$10.63B

IMNM

Immunome, Inc.

$22.94

-0.04%

$2.02B

Frequently Asked Questions

What is Arrowhead Pharmaceuticals, Inc.'s P/E ratio?

Arrowhead Pharmaceuticals, Inc. (0HI3.L) has a trailing twelve-month (TTM) P/E ratio of -68.05. This is below the market average, which may suggest the stock is undervalued or has lower growth expectations. The P/E ratio measures how much investors are willing to pay per dollar of earnings.

Does Arrowhead Pharmaceuticals, Inc. pay a dividend?

No, Arrowhead Pharmaceuticals, Inc. (0HI3.L) does not currently pay a regular dividend. The company may be reinvesting profits into growth, research, or debt reduction instead of returning cash to shareholders through dividends.

What is Arrowhead Pharmaceuticals, Inc.'s market cap?

Arrowhead Pharmaceuticals, Inc. (0HI3.L) has a market capitalization of $10.01 billion, classifying it as a large-cap company. Market cap is calculated by multiplying the current share price by the total number of outstanding shares.

How has 0HI3.L performed this year?

Arrowhead Pharmaceuticals, Inc. (0HI3.L) has returned -8.23% year-to-date. Past performance does not guarantee future results, but these figures reflect the stock's recent price trajectory relative to the broader market.